glp 1 example drugs GLP-1 Agonists Explained: Definition, How They Work, Side Effects What to Make of the

By choosing foods that naturally support your bodys production of this vital hormone, you can take charge of your health in a holistic and sustainable way

Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease

On the central role of mitochondria dysfunction and oxidative stress in alzheimers disease

S.RitzelR.et al (2002)

As a product of serendipity, the peptide exendin-4 from the saliva of a venomous lizard ( Heloderma suspectum , the Gila monster) was found to be homologous to mammalian GLP-1 and able to bind and activate GLP-1 receptors [13,14]

What is already known on this topic Glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors reduce the risk of cardiovascular and renal events in patients with type 2 diabetes These drug classes are increasingly used in combination when previous therapy with other antihyperglycaemic drugs fails Whether the combined use of these drug classes results in improved cardiovascular and renal outcomes in the real world setting, compared with the use of either drug class alone, remains unclear What this study adds This population based cohort study aimed at emulating a randomised controlled trial The combined use of a GLP-1 receptor agonist and an SGLT-2 inhibitor was associated with a lower risk of cardiovascular and serious renal events, compared with either drug class alone These findings highlight the potential benefit of combining these two effective drug classes in preventing cardiovascular and renal events in the treatment of type 2 diabetes Data availability statement This study is based on data from the Clinical Practice Research Datalink obtained under license from the UK Medicines and Healthcare products Regulatory Agency